Business | Drug mergers

Popping the question

THE drugs industry is one of the world's most regulated, but there is no ban on polygamy amongst its constituent firms. On the contrary, the practice is positively smiled upon. The announcement on January 20th that two firms, SmithKline Beecham (SB) and American Home Products (AHP), were talking about tying the knot has elicited applause from analysts and a surge in the shares of the entire drugs sector (AHP's in particular). The mooted merger would create the world's largest pill-pusher, with $14 billion in combined sales of prescription drugs. Time to crack open the champagne? Perhaps not.

This article appeared in the Business section of the print edition under the headline “Popping the question”

Clinton’s temptations

From the January 24th 1998 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Business

Protesters in favour of TikTok stand outside the United States Capitol.

TikTok’s time is up. Can Donald Trump save it?

The imperilled app hopes for help from an old foe

A tattooed man punches a large head, with motion lines and stars showing impact. He wears orange shorts.

The UFC, Dana White and the rise of bloodsport entertainment

There is more to the mixed-martial-arts impresario than his friendship with Donald Trump


A billboard welcoming the American electric car maker Tesla, in Monterrey, Mexico

Will Elon Musk scrap his plan to invest in a gigafactory in Mexico?

Donald Trump’s return to the White House may have changed Tesla’s plans


Germany is going nuts for Dubai chocolate

Will the hype last?

The year ahead: a message from the CEO

From the desk of Stew Pidd

One of the biggest energy IPOs in a decade could be around the corner

Venture Global, a large American gas exporter, is going public